References
- Eschbach J W, Abdulhadi M H, Browne J K, Delano R G, Downing M R, Egrie J C, et al. Results of a multicenter clinical trial with recombinant human erythropoietin in anemic patients with end-stage renal disease. Ann Intern Med 1989; 111: 992–1000
- Ludwig H, Fritz E, Leitgeh C, Krainer M, Kuhrer I, Sagaster P, Umek H. Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors. Ann Oncol 1993; 4: 161–167
- Goy A, Belanger C, Casadevall N, Picard F, Guesna M, Jaulmes D, Poisson D. High doses of intravenous recombinant human erythropoietin for the treatment of anaemia in myelodysplastic syndrome. Br J Haematol 1993; 84: 232–237
- Raine A EG. Hypertension, blood viscosity and cardiovascular morbidity in renal failure: implications of erythropoietin therapy. Lancet 1988; 1: 97–100
- Tepel M, Wischniowski H, Zidek W. Erythropoietin induced transmembrane calcium influx in essential hypertension. Life Sci 1992; 51: 161–167
- Schiffl H. Correlation of blood pressure in end-stage renal disease with platelet cytosolic free calcium concentration during treatment of renal anaemia with recombinant human erythropoietin. Int J Artif Organs 1992; 15: 393–398
- Martin J, Moncada S. Blood Pressure, erythropoietin and nitric oxide. Lancet 1988; 1: 644 L
- Satoh K, Masuda T, Ikeda Y, Kurokawa S, Kamata K, Kikawada R, Takamoto T, Marumo F. Hemodynamic changes by recombinant human erythropoietin therapy in hemodialyzed patients. Hypertension 1990; 15: 262–266
- Onoyama K, Hori K, Osato S, Fujishima M. Hemodynamic effect of recombinant human erythropoietin on hypotensive hemodialysis patients. Nephrol Dial Transplant 1991; 6: 562–565
- Hori K, Onoyama K, Iseki K, Fujimi S, Fujishima M. Hemodynamic and volume changes by recombinant human erythropoietin in the treatment of anemic hemodialysis patients. Clin Nephrol 1990; 33: 293–298
- Kamata K, Maruma F, Onoyama K. Hemodynamic mechanism of the elevation in blood pressure following the improvement of anemia with recombinant human erythropoietin. Japan Circ J 1991; 649–656
- Tagawa H, Nagana M, Saito H, et al. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin. Proposal for a haematocrit most beneficial to haemodynamics. Clin Nephrol 1991; 35: 35–38
- Paganini E, Thomas T, Fouad F, Garcia J, Bravo E. The correction of anemia in hemodialysis patients using recombinant human erythropoietin: hemodynamic effects. Kidney International 1988; 33: 204
- Nonnast-Daniel B, Creutzig A, Kuhn K, Bahlman K J, Reimers E, Brunkhorst R, et al. Effect of treatment with recombinant human erythropoietin on peripheral hemodynamics and oxygenation. Contrib Nephrol 1988; 66: 185–194
- Buckner F S, Eschbach J W, Haley R, Davidson R C, Adamson J W. Hypertension following erythropoietin therapy in anemic hemodialysis patients. Am J Hypertension 1990; 3: 947–955
- Creutzig A, Caspary L, Nonnast-Daniel B, Bahlmann J, Kuhn K, Brunkhorst R, Reimers E, Koch K M, Alexander K. Skin microcirculation and regional peripheral resistance in patients with chronic renal anaemia treated with recombinant human erythropoietin. Europ J Clin Invest 1990; 20: 219–223
- Fellner S K, Lang R M, Neumann A, Korcarz C, Borow K M. Cardiovascular consequences of correction of the anemia of renal failure with erythropoietin. Kidney Int 1993; 44: 1309–1315
- Bo Sramek B. Hemodynamic and pump-performance monitoring by electrical bioimpedance: new concepts. Problems in Respiratory Care 1989; 2(2)274–290, Eds. MacIntyre N and Branson RRT
- Mattar J A, et al. A clinical comparison between cardiac output measured by thermodilution versus noninvasive thoracic electrical bioimpedance. Acute Care 1986; 12: 58
- Appel P L, et al. Comparison of measurements of cardiac output by bioimpedance and thermodilution in severely ill surgical patients. Critical Care Med 1986; 14: 933–934
- Spinale F G, Reines H D, Cook M C, Crawford F A. Relationship of bioimpedance to thermodilution and echocardiographic measurements of cardiac function. Critical Care Med 1990; 18: 414–418
- O'Brien E, Mee F, Atkins N, O'Malley K. Accuracy of the Spacelabs 90207 determined by the British Hypertension Society Protocol. J Hypertension, 9: 573–574
- Heagerty A M, Bund S J, Izzard A S. Long-term structural changes in human hypertensive patients. Basic Res Cardiol, 86(suppl 1P)19–23